ArticleCancers2024

Targeting Tyro3, Axl, and MerTK Receptor Tyrosine Kinases Significantly Sensitizes Triple-Negative Breast Cancer to CDK4/6 Inhibition.

Seyma Demirsoy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.